Sfoglia per Autore
Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition
2010-01-01 F. Penna; D. Costamagna; A. Fanzani; G. Bonelli; F.M. Baccino; P. Costelli
Research update for articles published in EJCI in 2008
2010-01-01 C. Anderwald; H.J. Ankersmit; A. Badaoui; L. Beneduce; V.U. Buko; L.A. Calo; J.J. Carrero; C.Y. Chang; K.C. Chang; Y.J. Chen; M. Cnotliwy; P. Costelli; A.B. Crujeiras; A. Cuocolo; P.A. Davis; O.J. de Boer; C.F. Ebenbichler; C. Erridge; G. Fassina; S.B. Felix; M.C. García-Gómez; F. Guerrero-Romero; D.G. Haider; A. Heinemann; L.R. Herda; E.K. Hoogeveen; W.H. Hörl; B. Iglseder; K.C. Huang; S. Kaser; A. Kastrati; N. Kuzniatsova; G. Latella; M. Lichtenauer; Y.K. Lin; G.Y. Lip; N.H. Lu; O. Lukivskaya; P. Luschnig; M. Maniscalco; J.A. Martinez; S. Müller-Krebs; G. Ndrepepa; G. Nicolaou; M. Peck-Radosavljevic; F. Penna; X. Pintó; T. Reiberger; M. Rodriguez-Moran; A. Schmidt; V. Schwenger; L. Spinelli; P. Starkel; C.D. Stehouwer; P. Stenvinkel; P. Strasser; H. Suzuki; A. Tschoner; A.C. van der Wal; D.L. Vesely; C.J. Wen; I. Wiernicki; G. Zanninelli; Y. Zhu
Anticytokine strategies for the treatment of cancer-related anorexia and cachexia
2010-01-01 F. Penna; V.G. Minero; D. Costamagna; G. Bonelli; F.M. Baccino; P. Costelli
Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression
2010-01-01 Penna F.; Bonelli G.; Baccino F.M.; Costelli P.
Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved?
2010-01-01 Penna F.; Bonetto A.; Muscaritoli M.; Costamagna D.; Minero G.V.; Bonelli G.; Rossi Fanelli F.; Baccino F.M.; Costelli P.
ß-hydroxy-ß-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia
2011-01-01 Z. Aversa; A. Bonetto; P. Costelli; V.G. Minero; F. Penna; F.M. Baccino; S. Lucia; F. Rossi Fanelli; M. Muscaritoli
Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by Tumor Necrosis Factor-alpha
2011-01-01 A. Bonetto; F. Penna; V.G. Minero; P. Reffo; D. Costamagna; G. Bonelli; F.M. Baccino; P. Costelli
Combined approach to counteract experimental cancer cachexia: eicosapentenoic acid and training exercise
2011-01-01 F. Penna; S. Busquets; F. Pin; M. Toledo; F.M. Baccino; F.J. Lopez-Soriano; P. Costelli; J.M. Argilés
Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature
2011-01-01 E. Stoppani; S. Rossi; E. Meacci; F. Penna; P. Costelli; A. Bellucci; F. Faggi; D. Maiolo; E. Monti; A. Fanzani
Protein kinases in the pathogenesis of muscle wasting
2012-01-01 F. Penna; D. Costamagna; A. Camperi; M. Muscaritoli; F.M. Baccino; P. Costelli
Changes in myostatin signaling in non weight-losing cancer patients
2012-01-01 Z. Aversa; A. Bonetto; F. Penna; P. Costelli; G. di Rienzo; A. Lacitignola; F.M. Baccino; V. Ziparo; P. Mercantini; F. Rossi Fanelli; M. Muscaritoli
Are there any benefits for exercise training in cancer cachexia?
2012-01-01 J.M. Argilés; S. Busquets; F.J. Lopez-Soriano; P. Costelli; F. Penna
CASPASE 2 ACTIVATION AND ER STRESS DRIVE RAPID JURKAT CELL APOPTOSIS BY CLOFIBRATE
2012-01-01 F. Penna; F. Pin; D. Costamagna; P. Reffo; G. Bonelli; F.M. Baccino; P. Costelli
Molecular and cellular mechanisms of skeletal muscle atrophy: an update
2012-01-01 Fanzani A; Conraads VM; Penna F; Martinet W.
Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models
2013-01-01 F. Penna; S. Busquets; M. Toledo; F. Pin; D. Massa; F.J. López-Soriano; P. Costelli; J.M. Argilés
Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: Altered energetic efficiency?
2013-01-01 Fontes-Oliveira CC; Busquets S; Toledo M; Penna F; Aylwin MP; Sirisi S; Silva AP; Orpí M; García A; Sette A; Genovese MI; Olivan M; López-Soriano FJ; Argilés JM
Autophagic degradation contributes to muscle wasting in cancer cachexia
2013-01-01 F. Penna; D. Costamagna; F. Pin; A. Camperi; A. Fanzani; E.M. Chiarpotto; G. Cavallini; G. Bonelli; F.M. Baccino; P. Costelli
Early changes of muscle IGF-1 and myostatin gene expression in gastric cancer patients
2013-01-01 A. Bonetto; F. Penna; Z. Aversa; P. Mercantini; F.M. Baccino; P. Costelli; V. Ziparo; S. Lucia; F. Rossi Fanelli; M. Muscaritoli
Mechanism-based therapeutic approaches to cachexia
2013-01-01 F. Penna; G. Bonelli; F.M. Baccino; P. Costelli
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma
2014-01-01 F. Faggi; S. Mitola; G. Sorci; F. Riuzzi; S. Rossi; S. Codenotti; P.L. Poliani; M. Cominelli; R. Vescovi; S. Calza; F. Penna; P. Costelli; I. Perini; M. Sampaolesi; E. Monti; A. Fanzani
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Muscle wasting and impaired myogenesis in tumor bearing mice are prevented by ERK inhibition | 2010 | F. Penna; D. Costamagna; A. Fanzani; G. Bonelli; F.M. Baccino; P. Costelli | |
| Research update for articles published in EJCI in 2008 | 2010 | C. Anderwald; H.J. Ankersmit; A. Badaoui; L. Beneduce; V.U. Buko; L.A. Calo; J.J. Carrero; C.Y. Chang; K.C. Chang; Y.J. Chen; M. Cnotliwy; P. Costelli; A.B. Crujeiras; A. Cuocolo; P.A. Davis; O.J. de Boer; C.F. Ebenbichler; C. Erridge; G. Fassina; S.B. Felix; M.C. García-Gómez; F. Guerrero-Romero; D.G. Haider; A. Heinemann; L.R. Herda; E.K. Hoogeveen; W.H. Hörl; B. Iglseder; K.C. Huang; S. Kaser; A. Kastrati; N. Kuzniatsova; G. Latella; M. Lichtenauer; Y.K. Lin; G.Y. Lip; N.H. Lu; O. Lukivskaya; P. Luschnig; M. Maniscalco; J.A. Martinez; S. Müller-Krebs; G. Ndrepepa; G. Nicolaou; M. Peck-Radosavljevic; F. Penna; X. Pintó; T. Reiberger; M. Rodriguez-Moran; A. Schmidt; V. Schwenger; L. Spinelli; P. Starkel; C.D. Stehouwer; P. Stenvinkel; P. Strasser; H. Suzuki; A. Tschoner; A.C. van der Wal; D.L. Vesely; C.J. Wen; I. Wiernicki; G. Zanninelli; Y. Zhu | |
| Anticytokine strategies for the treatment of cancer-related anorexia and cachexia | 2010 | F. Penna; V.G. Minero; D. Costamagna; G. Bonelli; F.M. Baccino; P. Costelli | |
| Cytotoxic properties of clofibrate and other peroxisome proliferators: relevance to cancer progression | 2010 | Penna F.; Bonelli G.; Baccino F.M.; Costelli P. | |
| Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? | 2010 | Penna F.; Bonetto A.; Muscaritoli M.; Costamagna D.; Minero G.V.; Bonelli G.; Rossi Fanelli F.; Baccino F.M.; Costelli P. | |
| ß-hydroxy-ß-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia | 2011 | Z. Aversa; A. Bonetto; P. Costelli; V.G. Minero; F. Penna; F.M. Baccino; S. Lucia; F. Rossi Fanelli; M. Muscaritoli | |
| Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by Tumor Necrosis Factor-alpha | 2011 | A. Bonetto; F. Penna; V.G. Minero; P. Reffo; D. Costamagna; G. Bonelli; F.M. Baccino; P. Costelli | |
| Combined approach to counteract experimental cancer cachexia: eicosapentenoic acid and training exercise | 2011 | F. Penna; S. Busquets; F. Pin; M. Toledo; F.M. Baccino; F.J. Lopez-Soriano; P. Costelli; J.M. Argilés | |
| Point mutated Caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature | 2011 | E. Stoppani; S. Rossi; E. Meacci; F. Penna; P. Costelli; A. Bellucci; F. Faggi; D. Maiolo; E. Monti; A. Fanzani | |
| Protein kinases in the pathogenesis of muscle wasting | 2012 | F. Penna; D. Costamagna; A. Camperi; M. Muscaritoli; F.M. Baccino; P. Costelli | |
| Changes in myostatin signaling in non weight-losing cancer patients | 2012 | Z. Aversa; A. Bonetto; F. Penna; P. Costelli; G. di Rienzo; A. Lacitignola; F.M. Baccino; V. Ziparo; P. Mercantini; F. Rossi Fanelli; M. Muscaritoli | |
| Are there any benefits for exercise training in cancer cachexia? | 2012 | J.M. Argilés; S. Busquets; F.J. Lopez-Soriano; P. Costelli; F. Penna | |
| CASPASE 2 ACTIVATION AND ER STRESS DRIVE RAPID JURKAT CELL APOPTOSIS BY CLOFIBRATE | 2012 | F. Penna; F. Pin; D. Costamagna; P. Reffo; G. Bonelli; F.M. Baccino; P. Costelli | |
| Molecular and cellular mechanisms of skeletal muscle atrophy: an update | 2012 | Fanzani A; Conraads VM; Penna F; Martinet W. | |
| Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models | 2013 | F. Penna; S. Busquets; M. Toledo; F. Pin; D. Massa; F.J. López-Soriano; P. Costelli; J.M. Argilés | |
| Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: Altered energetic efficiency? | 2013 | Fontes-Oliveira CC; Busquets S; Toledo M; Penna F; Aylwin MP; Sirisi S; Silva AP; Orpí M; García A; Sette A; Genovese MI; Olivan M; López-Soriano FJ; Argilés JM | |
| Autophagic degradation contributes to muscle wasting in cancer cachexia | 2013 | F. Penna; D. Costamagna; F. Pin; A. Camperi; A. Fanzani; E.M. Chiarpotto; G. Cavallini; G. Bonelli; F.M. Baccino; P. Costelli | |
| Early changes of muscle IGF-1 and myostatin gene expression in gastric cancer patients | 2013 | A. Bonetto; F. Penna; Z. Aversa; P. Mercantini; F.M. Baccino; P. Costelli; V. Ziparo; S. Lucia; F. Rossi Fanelli; M. Muscaritoli | |
| Mechanism-based therapeutic approaches to cachexia | 2013 | F. Penna; G. Bonelli; F.M. Baccino; P. Costelli | |
| Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma | 2014 | F. Faggi; S. Mitola; G. Sorci; F. Riuzzi; S. Rossi; S. Codenotti; P.L. Poliani; M. Cominelli; R. Vescovi; S. Calza; F. Penna; P. Costelli; I. Perini; M. Sampaolesi; E. Monti; A. Fanzani |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile